DataMeds AI, Inc. — Form 8-K
Filed October 20, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
DataMeds AI (NASDAQ: MEDS) received notification on October 19, 2026, that it has regained compliance with NASDAQ Listing Rule 5550(b)(1) by exceeding the minimum $2.5 million stockholders' equity requirement. The company had been at delisting risk since April 13, 2026, for failing both the $1.00 bid-price test and the equity minimum; it achieved bid-price compliance by June 9, 2026, and equity compliance by October 19, 2026, based on material events disclosed in October 13–16, 2026 Form 8-K filings. The company faces renewed delisting risk if it fails to maintain compliance at its next periodic report filing.
Why this rating
Delisting avoidance is material for a $27.1M company; direct existential threat removed. Compliance restoration is stabilizing but fragile—renewed compliance failure risk remains high.
Tradability signal
NO TRADE
No trade: positive news with only -0.2% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.09% over 4 hrs, n=266). (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $2.62 ▲ 0.19% | at our read · unknown $2.62 | +10 min · unknown $2.61 ▼ 0.19% | +30 min · unknown $2.60 ▼ 0.38% | +1 hr pending | +4 hrs pending |
The stock had already moved -0.19% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.